Response to "comment on "aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al."

Affiliations

¹ Department of Cardiology, Heart Center, Medical Library, Academic Medical Center, Amsterdam, The Netherlands.
² Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia.
³ Department of Cardiology, Heart Center, Medical Library, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: j.r.degroot@amc.uva.nl.

Free article

Comment

J Neefs et al. Int J Cardiol. 2017.

Free article

. 2017 Sep 1:242:23.

doi: 10.1016/j.ijcard.2017.03.007.

¹ Department of Cardiology, Heart Center, Medical Library, Academic Medical Center, Amsterdam, The Netherlands.
² Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia.
³ Department of Cardiology, Heart Center, Medical Library, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: j.r.degroot@amc.uva.nl.

No abstract available

Comment on

Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Neefs J, van den Berg NW, Limpens J, Berger WR, Boekholdt SM, Sanders P, de Groot JR. Neefs J, et al. Int J Cardiol. 2017 Mar 15;231:155-161. doi: 10.1016/j.ijcard.2016.12.029. Epub 2016 Dec 23. Int J Cardiol. 2017. PMID: 28062142
Comment on "Aldosterone pathway blockade to prevent atrial fibrillation: A systematic review and meta-analysis" by Neefs et al.
Alexandre J, Sezai A, Milliez P. Alexandre J, et al. Int J Cardiol. 2017 Sep 1;242:22. doi: 10.1016/j.ijcard.2017.01.115. Int J Cardiol. 2017. PMID: 28619325 No abstract available.